This compound is a pharmaceutical intermediate featuring a brominated pyridine ring and a morpholine amide moiety. It is primarily used in the synthesis of drug candidates, particularly those requiring a difluoromethyl ketone functional group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 2-(5-BROMOPYRIDIN-2-YL)-2,2-DIFLUORO-1-MORPHOLINOETHAN-1-ONE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Methyl 5-chloro-3,4-dihydroxy-2-methylbenzoate
pharmaceutical intermediate
Methanone, (2-amino-5-chlorophenyl)phenyl-, oxime
pharmaceutical intermediate
5-Chloro-3-nitropyridine-2-carbonitrile
pharmaceutical intermediate
Methyl 2-[(3S)-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate
pharmaceutical intermediate
2-(5-bromo-2-pyridinyl)-2,2-difluoro-1-morpholin-4-ylethanone
LOZRMBNPPOSKKN-UHFFFAOYSA-N
C1COCCN1C(=O)C(C2=NC=C(C=C2)Br)(F)F
—
Sourcing 2-(5-BROMOPYRIDIN-2-YL)-2,2-DIFLUORO-1-MORPHOLINOETHAN-1-ONE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.